CACLP Announces New Date and Venue for the Highly Anticipated 2025 Event
By LabMedica International staff writers Posted on 14 Oct 2024 |

Impressive numbers from CACLP 2024
In March 2024, the tradeshows were a resounding success, showcasing a diverse array of products and technologies from participants. The events drew an impressive 1,346 exhibitors and 42,751 visitors from China and 40 other countries, all gathered in a sprawling exhibition space of 130,000 sqm.
A series of academic activities featured 125 scientific lectures with 315 academic speakers and attracted over 5,000 delegates. These activities garnered 462,150 online views through CACLP’s WeChat channels and app.
Hangzhou: the ideal host for CACLP 2025
The upcoming event will return to Hangzhou, offering global participants a convenient and enriching experience in the newly opened Hangzhou Grand Convention & Exhibition Center.
Located in the heart of the economically vibrant Yangtze River Delta, Hangzhou offers convenient transportation, advanced innovation, and abundant natural and cultural resources. This enchanting city provides an ideal environment for the IVD industry. There are 6,626 medical and healthcare institutions in Hangzhou, including 414 hospitals and 27 top-tier (Grade A, Level 3) hospitals. Hangzhou has also pioneered China’s first dedicated IVD industry promotion institute to bolster local industry development.
With China’s favorable visa-free policy, international participants will find it easier than ever to join, and discover an optimal setting for collaboration, extensive networking, and exploration of the latest market trends and innovations.
Academic Highlights in Hangzhou
Numerous professionals across the whole IVD industry chain are expected take part in the concurrent academic activities, such as the 10th China Experimental Medicine Conference (CEMC) and series sessions and the 12th China IVD Industry Development Conference (CIIDC) and series forums.
These activities will include in-depth discussions on hot topics in laboratory medicine and IVD, with renowned experts and scholars presenting cutting-edge research findings, while industry leaders exchange valuable experiences.
"Bringing IVD people together!" embodies our commitment to always foster unity and progress within the industry. Join us in Hangzhou for CACLP 2025!
Interested in exhibiting or seeking more information? Leave your message here and we will get back to you very soon: https://en.caclp.com/exhibit-reserve.html
About GL events
GL events is a world-class leading provider of integrated solutions and services for events operating across the 3 major core divisions: Venues (venue management), Exhibitions (exhibition organizing) and Live (event services).
Through its wide global network made up of more than 90 offices, with organizing over 480 proprietary trade fair and events, managing more than 60 venues, and staging more than 4,200 events every year, GL events Group is a critical force for city promotion of 28 MICE destinations.
Present on five continents with operations in more than 20 countries, GL events has over 5,119 employees. Listed on the Eurolist Euronext Compartment B (Paris Stock Exchange), GL events had a turnover of €1.315bn in 2022.
About CACLP
Debut launched in 1991, China International In Vitro Diagnostic Expo by CACLP, is well established as one of the largest exhibitions in the in vitro diagnostic industry worldwide. China IVD Supply Chain Expo, successfully launched in 2021, further expands the product sectors from upstream to downstream. With a great number of high-level academic and educational programs held concurrently onsite, and year-round promotional solutions, CACLP proves itself as one of the most important platforms for global IVD players.
In 2020, CACLP formed the joint-venture company with GL events to start the internationalism strategy.
Latest Focus News
- Join TianLong at ADLM 2024 to Explore the Latest Diagnostic Innovations!
- Tianlong was Showcased in the METROLOGIA LAB SUMMIT and the SBBQ 53rd Annual Meeting in Brazil with Integrated PCR Lab Solutions
- Tianlong’s Latest All-in-one Molecular Diagnosis system - Panall 8000 Open System
- Meet TianLong at the 73rd Annual Convention of Philippine Society of Pathologist
- TianLong Participated in the International Medical Congress of SCO Countries in Kyrgyzstan
- TianLong HPV Nucleic Acid Detection Kit Could Enable Early Detection of Cervical Cancer
- Meet TianLong’s NEWLY LAUNCHED Real-Time PCR System - Gentier X3 Series
- TianLong Solution Facilitates the Prevention and Control of Livestock Diseases
- TianLong Solution Facilitates the Prevention and Control of Livestock Diseases
- Tianlong Showcases Latest Real-Time PCR System and Innovative Molecular Diagnostic Solutions at MEDICA 2023
- TianLong Will Exhibit at MEDICA 2023 in Messe Düsseldorf of Germany
- Tianlong at PhilMedical 2023 Expo | More to Expect!
- INVITATION! Meet us at the Brazilian Society of Clinical Analysis 2023
- Good News!- Tianlong has helped build up the HCV&HBV detection line for hospitals in northern Thailand!
- PANA9600X Automatic Nucleic Acid Workstation
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. There is a growing need to identify this risk from birth... Read more
Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
Parkinson’s disease is a neurodegenerative condition typically diagnosed at an advanced stage based on clinical symptoms, primarily motor disorders. However, by this time, the brain has already undergone... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more